Evidence map›Paper›PMID 41080917›Full record

ArticleO&G open2025

Evaluating E-Visit Utilization and Efficacy for Oral Contraceptive Pills in a Large, Integrated Health Care System.

Eve Zaritsky, Dana Sax, Emily Bolton, Jeitzel M Torres-Rodriguez, Ameek K Bindra, Jie Huang, Mary Reed

Abstract read
In one paragraph

Article in O&G open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eve ZaritskyObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.
Dana SaxObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.
Emily BoltonObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.
Jeitzel M Torres-RodriguezObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.
Ameek K BindraObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.
Jie HuangObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.
Mary ReedObstetrics and Gynecology and Emergency Medicine, Kaiser Permanente Oakland Medical Center, Oakland, and the Division of Research, Kaiser Permanente Oakland Medical Center, Pleasanton, California.

Funding

Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
NIDDK NIH HHS P30 DK092924
6 · The paper itself

Abstract

objectiveTo describe and compare outcomes, including access to care, timeliness of care, and need for a close follow-up visit, by the following visit modalities: office, telephone, video, and e-visit for women seeking oral contraceptive care.

methodsWe conducted a retrospective cohort study of all Kaiser Permanente Northern California patient-initiated encounters in the department of obstetrics and gynecology with a primary diagnosis related to oral contraceptive care in 2023 among women aged 18-50 years, excluding those who were not pregnant or those seeking nonoral contraceptive methods. Outcomes included the time from care initiation to oral contraceptive order, rates of contraceptive orders and pickups, the time from care initiation to medication pickup, and rates of 7-day in-person clinic follow-up by visit modality. Covariates included age, race and ethnicity, neighborhood socioeconomic status, primary language, and comorbidity burden (Elixhauser Comorbidity Index score). Using multivariable regression, we calculated marginal adjusted estimates by modality.

resultsAmong 23,122 encounters, the median patient age was 28 years; 20.9% of the women were Asian, 8.9% Black, 32.7% Hispanic, 36.2% non-Hispanic White, and 1.4% none of the above. Telemedicine was more frequently chosen than in-office visits, with 49.3% choosing visits by telephone, 9.9% by video, and 13.7% by e-visit; 27.1% chose office visits. After adjusting for patient characteristics, women who chose e-visits, compared with those who chose an office visit, were more likely to be Black, Hispanic, or Asian (vs White), more likely to primarily speak English, and less likely to have comorbid illnesses. E-visits had the highest adjusted rate of contraceptive orders (92.0%, 95% CI, 91.1-93.0%) and the lowest adjusted rate of 7-day in-person follow-up. All telemedicine modalities had higher contraceptive pickup rates compared with office visits (61.6%). However, rates were slightly higher for telephone (76.7%) and video (76.2%) visits than for e-visits (73.2%). E-visits were associated with the timeliest care: Contraceptive orders were placed 11.3 days faster (95% CI, 10.9-11.8), and pickups occurred 9.5 days sooner (95% CI, 7.7-11.3) compared with office visits.

conclusionE-visits for oral contraceptive care may offer a timely and patient-centered method of care delivery with more timely contraceptive orders and pickups and less need for short-term follow-up, compared with other visit modalities. Asynchronous telemedicine presents as an emerging opportunity to increase access to contraceptive care.

Identifiers

PMID41080917
PMCPMC12513448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.